Rucinol

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

4-Butyl-benzol-1,3-diol; 4-n-butylresorcinol

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Synthetic resorcinol compound used as an active ingredient in the treatment of hyperpigmentation of the skin. Rucinol inhibits tyrosinase, the key enzyme in melanin synthesis. Furthermore it inhibits TRP-1, the tyrosinase-related protein-1. The effect of rocinol on the melanin production seems to be considerably stronger than that of hydroquinone and kojic acid.

IndicationThis section has been translated automatically.

hyperpigmentation of the skin; chloasma, lentigo solaris, lentigo senilis

Note(s)This section has been translated automatically.

In Germany, cosmetics containing rocinol have been available in the form of serum and cream since January 2005. The effectiveness and tolerance of the substance has been proven by several clinical studies.

LiteratureThis section has been translated automatically.

  1. Khemis A et al (2007) Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. Br J Dermatol 156:997-1004
  2. Konda S et al (2012 New horizons in treating disorders of hyperpigmentation in skin of color. Semin Cutan Med Surg 31:133-139

Authors

Last updated on: 29.10.2020